Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Purchases of marketable securities | (127,744) | (89,262) |
| Proceeds from maturities and sales of marketable securities | 101,346 | 129,121 |
| Milestone payment for intangible asset | — | (10,000) |
| Purchases of property and equipment | (158) | (686) |
| Net cash provided by (used in) investing activities | (26,556) | 29,173 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Proceeds from issuance of common stock upon exercise of stock options | 2,428 | 456 |
| Proceeds from issuance of common stock pursuant to employee stock purchase plan | 1,629 | 1,319 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Arcutis Biotherapeutics, Inc.'s capex?
- Arcutis Biotherapeutics, Inc. (ARQT) reported capex of $158K in Q2 2026.
- How has Arcutis Biotherapeutics, Inc.'s capex changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s capex increased by 102.6% year-over-year, from $78K to $158K.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s capex?
- Over 3 years (2021 to 2024), Arcutis Biotherapeutics, Inc.'s capex has grown at a -47.6% compound annual growth rate (CAGR), from $995K to $143K.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Arcutis Biotherapeutics, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude